Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin : one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.

Keyword

Aged

Aged; 80 and over

Antibodies; Monoclonal/*administration & dosage

Aspirin/administration & dosage

Drug Administration Schedule

Drug Therapy; Combination

Enoxaparin/*administration & dosage

Female

Fibrinolytic Agents/therapeutic use

Follow-Up Studies

Heparin/administration & dosage/*analogs & derivatives

Humans

Immunoglobulins; Fab/*administration & dosage

Infusions; Intravenous

Injections; Intravenous

Injections; Subcutaneous

Male

Middle Aged

Myocardial Infarction/*drug therapy/mortality

Research Support; Non-U.S. Gov't

Survival Rate

Tissue Plasminogen Activator/*administration & dosage

Publication and Content Type

ref (subject category)

art (subject category)